Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 32,550 shares at $104.08 ($3.3M) on 2023-02-08, disclosed to the SEC on 2023-02-08.
Seasonal sale ($3.3M) by Chief Legal Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.80 | 1,041 | $110K | 3.3% |
| 2 | $105.80 | 1,041 | $110K | 3.3% |
| 3 | $102.24 | 1,522 | $156K | 4.7% |
| 4 | $102.24 | 1,522 | $156K | 4.7% |
| 5 | $102.42 | 12,801 | $1.3M | 39.2% |
| 6 | $102.42 | 12,801 |
| $1.3M |
| 39.2% |
| 7 | $104.08 | 911 | $95K | 2.8% |
| 8 | $104.08 | 911 | $95K | 2.8% |
| Total | $102.71 avg | 32,550 | $3.3M | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |